Serum Institute of India Revenue and Competitors

Pune, IND

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Serum Institute of India's estimated annual revenue is currently $412.8M per year.(i)
  • Serum Institute of India's estimated revenue per employee is $77,500

Employee Data

  • Serum Institute of India has 5327 Employees.(i)
  • Serum Institute of India grew their employee count by 6% last year.

Serum Institute of India's People

NameTitleEmail/Phone
1
Executive OfficerReveal Email/Phone
2
Executive OfficerReveal Email/Phone
3
OfficerReveal Email/Phone
4
Assistant OfficerReveal Email/Phone
5
Executive OfficerReveal Email/Phone
6
Executive OfficerReveal Email/Phone
7
Executive OfficerReveal Email/Phone
8
Executive OfficerReveal Email/Phone
9
Executive OfficerReveal Email/Phone
10
Executive OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is Serum Institute of India?

Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world. Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties. Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines. The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world are protected from birth onwards.

keywords:N/A

N/A

Total Funding

5327

Number of Employees

$412.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Serum Institute of India News

2022-04-19 - With 200M unused doses, AstraZeneca's COVID vaccine ...

Serum Institute of India (SII) stopped making new COVID-19 vaccine doses in December, CEO Adar Poonawalla said at the India Economic...

2022-04-19 - Adar Poonawalla says Serum Institute has stopped vaccine production to avoid waste

Serum Institute of India CEO Adar Poonawalla on Friday warned against the return to the business-as-usual approach, saying we “can't afford...

2022-04-19 - World's Biggest Vaccine Maker Serum Halts Production Over ...

Serum Institute of India Ltd., the world's largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1468.3M67337%$602.4M
#2
$700.4M71473%N/A
#3
$883.5M87915%N/A